Notice2025-23478
Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 19, 2025
Issuing agencies
Transportation DepartmentFederal Motor Carrier Safety Administration
Abstract
FMCSA announces receipt of applications from 52 individuals for an exemption from the prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs) against persons with a clinical diagnosis of epilepsy or any other condition that is likely to cause a loss of consciousness or any loss of ability to control a commercial motor vehicle (CMV) to drive in interstate commerce. If granted, the exemptions would enable these individuals who have had one or more seizures and are taking anti-seizure medication to operate CMVs in interstate commerce.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 242 (Friday, December 19, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 242 (Friday, December 19, 2025)]
[Notices]
[Pages 59636-59640]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-23478]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2025-0009]
Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of applications for exemption; request for comments.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces receipt of applications from 52 individuals
for an exemption from the prohibition in the Federal Motor Carrier
Safety Regulations (FMCSRs) against persons with a clinical diagnosis
of epilepsy or any other condition that is likely to cause a loss of
consciousness or any loss of ability to control a commercial motor
vehicle (CMV) to drive in interstate commerce. If granted, the
exemptions would enable these individuals who have had one or more
seizures and are taking anti-seizure medication to operate CMVs in
interstate commerce.
DATES: Comments must be received on or before January 20, 2026.
ADDRESSES: You may submit comments identified by Docket No. FMCSA-2025-
0009 using any of the following methods:
<bullet> Federal eRulemaking Portal: Go to <a href="http://www.regulations.gov">www.regulations.gov</a>,
insert the docket number (FMCSA-2025-0009) in the keyword box and click
``Search.'' Next, choose the only notice listed, and click on the
``Comment'' button. Follow the online instructions for submitting
comments.
<bullet> Mail: Dockets Operations; U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor,
Washington, DC 20590-0001.
<bullet> Hand Delivery: West Building Ground Floor, 1200 New Jersey
Avenue SE, Washington, DC 20590-0001 between 9 a.m. and 5 p.m. ET
Monday through Friday, except Federal Holidays.
<bullet> Fax: (202) 493-2251.
To avoid duplication, please use only one of these four methods.
See the ``Public Participation'' portion of the SUPPLEMENTARY
INFORMATION section for instructions on submitting comments.
FOR FURTHER INFORMATION CONTACT: Ms. Christine Hydock, Chief, Medical
Programs Division, FMCSA, DOT, 1200 New Jersey Avenue SE, Washington,
DC 20590-0001, (202) 366-4001, <a href="/cdn-cgi/l/email-protection#d7b1bab4a4b6bab2b3beb4b6bb97b3b8a3f9b0b8a1"><span class="__cf_email__" data-cfemail="8ee8e3edfdefe3ebeae7edefe2ceeae1faa0e9e1f8">[email protected]</span></a>. Office hours are
8:30 a.m. to 5 p.m. ET Monday through Friday, except Federal holidays.
If you have questions regarding viewing or submitting material to the
docket, contact Dockets Operations, (202) 366-9826.
SUPPLEMENTARY INFORMATION:
I. Public Participation
A. Submitting Comments
If you submit a comment, please include the docket number for this
notice (Docket No. FMCSA-2025-0009), indicate the specific section of
this document to which each comment applies, and provide a reason for
each suggestion or recommendation. You may submit your comments and
material online or by fax, mail, or hand delivery, but please use only
one of these means. FMCSA recommends that you include your name and a
mailing address, an email address, or a phone
[[Page 59637]]
number in the body of your document so that FMCSA can contact you if
there are questions regarding your submission.
To submit your comment online, go to <a href="https://www.regulations.gov/docket/FMCSA-2025-0009">https://www.regulations.gov/docket/FMCSA-2025-0009</a>. Next, choose the only notice listed, click the
``Comment'' button, and type your comment into the text box on the
following screen. Choose whether you are submitting your comment as an
individual or on behalf of a third party and then submit.
If you submit your comments by mail or hand delivery, submit them
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for
copying and electronic filing. FMCSA will consider all comments and
material received during the comment period.
B. Confidential Business Information (CBI)
CBI is commercial or financial information that is both customarily
and actually treated as private by its owner. Under the Freedom of
Information Act (5 U.S.C. 552), CBI is exempt from public disclosure.
If your comments responsive to the notice contain commercial or
financial information that is customarily treated as private, that you
actually treat as private, and that is relevant or responsive to the
notice, it is important that you clearly designate the submitted
comments as CBI. Please mark each page of your submission that
constitutes CBI as ``PROPIN'' to indicate it contains proprietary
information. FMCSA will treat such marked submissions as confidential
under the Freedom of Information Act, and they will not be placed in
the public docket of the notice. Submissions containing CBI should be
sent to Brian Dahlin, Chief, Regulatory Evaluation Division, Office of
Policy, FMCSA, 1200 New Jersey Avenue SE, Washington, DC 20590-0001 or
via email at <a href="/cdn-cgi/l/email-protection#b2d0c0dbd3dc9cd59cd6d3dadedbdcf2d6ddc69cd5ddc4"><span class="__cf_email__" data-cfemail="95f7e7fcf4fbbbf2bbf1f4fdf9fcfbd5f1fae1bbf2fae3">[email protected]</span></a>. At this time, you need not send a
duplicate hardcopy of your electronic CBI submissions to FMCSA
headquarters. Any comments FMCSA receives not specifically designated
as CBI will be placed in the public docket for this notice.
C. Viewing Comments
To view comments, go to <a href="http://www.regulations.gov">www.regulations.gov</a>, insert the docket
number (FMCSA-2025-0009) in the keyword box and click ``Search.'' Next,
choose the only notice listed, and click ``Browse Comments.'' If you do
not have access to the internet, you may view the docket online by
visiting Dockets Operations on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE, Washington, DC 20590-0001, between
9 a.m. and 5 p.m. ET Monday through Friday, except Federal holidays. To
be sure someone is there to help you, please call (202) 366-9317 or
(202) 366-9826 before visiting Dockets Operations.
D. Privacy Act
In accordance with 49 U.S.C. 31315(b)(6), DOT solicits comments
from the public on the exemption request. DOT posts these comments,
including any personal information the commenter provides, to
<a href="http://www.regulations.gov">www.regulations.gov</a>, as described in the system of records notice DOT/
ALL-14 FDMS (Federal Docket Management System), which can be reviewed
under the ``Department Wide System of Records Notices'' link at <a href="https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices">https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices</a>. The comments are posted without edit and are searchable by the
name of the submitter.
II. Legal Basis
FMCSA has authority under 49 U.S.C. 31136(e) and 31315(b) to grant
exemptions from the Federal Motor Carrier Safety Regulations (FMCSRs).
FMCSA must publish a notice of each exemption request in the Federal
Register (49 CFR 381.315(a)). The Agency must provide the public an
opportunity to inspect the information relevant to the application,
including the applicant's safety analysis. The Agency must provide an
opportunity for public comment on the request.
The Agency reviews the application, safety analyses, and public
comments submitted and determines whether granting the exemption would
likely achieve a level of safety equivalent to, or greater than, the
level that would be achieved absent such exemption, pursuant to the
standard set forth 49 U.S.C. 31315(b)(1). The Agency must publish its
decision in the Federal Register (49 CFR 381.315(b)). If granted, the
notice will identify the regulatory provision from which the applicant
will be exempt, the effective period, and all terms and conditions of
the exemption (49 CFR 381.315(c)(1)). If the exemption is denied, the
notice will explain the reason for the denial (49 CFR 381.315(c)(2)).
The exemption may be renewed (49 CFR 381.300(b)). FMCSA grants medical
exemptions from the FMCSRs for a 2-year period to align with the
maximum duration of a driver's medical certification.
III. Background
The physical qualification standard for drivers regarding seizures
and loss of consciousness provides that a person is physically
qualified to drive a CMV if that person has ``no established medical
history or clinical diagnosis of epilepsy or any other condition which
is likely to cause the loss of consciousness or any loss of ability to
control'' a CMV (49 CFR 391.41(b)(8)). To assist in applying this
standard, FMCSA publishes guidance for medical examiners (ME) in the
form of medical advisory criteria in Appendix A to 49 CFR part 391.\1\
In 2007, FMCSA published recommendations from a Medical Expert Panel
(MEP) that FMCSA tasked to review the existing seizure disorder
guidelines for MEs.\2\ The MEP performed a comprehensive, systematic
literature review, including evidence available at the time. The MEP
issued recommended criteria to evaluate whether an individual with a
history of epilepsy, a single unprovoked seizure, or a provoked seizure
should be allowed to drive a CMV.
---------------------------------------------------------------------------
\1\ 49 CFR part 391, App.A.II.G, available at <a href="https://www.ecfr.gov/current/title-49/subtitle-B/chapter-III/subchapter-B/part-391/appendix-Appendix%20A%20to%20Part%20391">https://www.ecfr.gov/current/title-49/subtitle-B/chapter-III/subchapter-B/part-391/appendix-Appendix%20A%20to%20Part%20391</a>.
\2\ ``Expert Panel Recommendations, Seizure Disorders and
Commercial Motor Vehicle Driver Safety,'' Medical Expert Panel (Oct.
15, 2007), available at <a href="https://www.fmcsa.dot.gov/sites/fmcsa.dot.gov/files/2020-04/Seizure-Disorders-MEP-Recommendations-v2-prot%2010152007.pdf">https://www.fmcsa.dot.gov/sites/fmcsa.dot.gov/files/2020-04/Seizure-Disorders-MEP-Recommendations-v2-prot%2010152007.pdf</a>.
---------------------------------------------------------------------------
On January 15, 2013, FMCSA began granting exemptions, on a case-by-
case basis, to individual drivers from the physical qualification
standard regarding seizures and loss of consciousness in 49 CFR
391.41(b)(8) (78 FR 3069). The Agency considers the medical advisory
criteria, the 2007 MEP recommendations, any public comments received,
and each individual's medical information and driving record in
deciding whether to grant the exemption.
The 52 individuals listed in this notice have requested an
exemption from the epilepsy and seizure disorders prohibition in 49 CFR
391.41(b)(8). Accordingly, the Agency will evaluate the qualifications
of each applicant to determine whether granting the exemption will
achieve the required level of safety mandated by statute.
IV. Qualifications of Applicants
Matthew Archer
Matthew Archer is a 31-year-old class R license holder in Colorado.
He has a history of epilepsy and has been seizure free since January 4,
2015. He takes an anti-seizure medication with the dosage and frequency
remaining the same since February 10, 2025. His physician states that
they are supportive of him receiving an exemption.
[[Page 59638]]
Scott Bair
Scott Bair is a 24-year-old class C license holder in California.
He has a history of epilepsy and has been seizure free since October 1,
2021. He takes anti-seizure medication with the dosage and frequency
remaining the same since 2021. His physician states that they are
supportive of him receiving an exemption.
Rosemarie Black
Rosemarie Black is a 35-year-old class D license holder in Alaska.
She has a history of epilepsy and has been seizure free since July 2,
2019. She takes anti-seizure medication with the dosage and frequency
remaining the same since 2019. Her physician states that they are
supportive of her receiving an exemption.
Roger Boll
Roger Boll is a 27-year-old class A commercial driver's license
(CDL) holder in Missouri. He has a history of juvenile myoclonic
epilepsy and has been seizure free since July 2020. He takes an anti-
seizure medication with the dosage and frequency remaining the same
since July 13, 2020. His physician states that they are supportive of
him receiving an exemption.
Stephen Bridges
Stephen Bridges is a 32-year-old class D driver's license holder in
South Carolina. He has a history of complex partial epilepsy and has
been seizure free since May 10, 2020. He takes anti-seizure medication
with the dosage and frequency remaining the same since 2020. His
physician states that they are supportive of him receiving an
exemption.
William Brock
William Brock is a 29-year-old class D driver's license holder in
Tennessee. He has a history of complex partial seizures and has been
seizure free since May 3, 2022. He takes anti-seizure medication with
the dosage and frequency remaining the same since November 2, 2022. His
physician states that they are supportive of him receiving an
exemption.
Cory Broyles
Cory Broyles is a 36-year-old class AM CDL holder in Georgia. He
has a history of epilepsy and has been seizure free since August 2015.
He takes an anti-seizure medication with the dosage and frequency
remaining the same since February 2025. His physician states that they
are supportive of him receiving an exemption.
Derick Buxton
Derick Buxton is a 33-year-old class C driver's license holder in
Pennsylvania. He has a history of left frontal anaplastic astrocytoma
and has been seizure free since March 19, 2022. He takes anti-seizure
medication with the dosage and frequency remaining the same since 2024.
His physician states that they are supportive of him receiving an
exemption.
Luis Castillo
Luis Castillo is a 56-year-old class A CDL holder in Colorado. He
has a history of unspecified convulsions and has been seizure free
since January 24, 2025. He takes anti-seizure medication with the
dosage and frequency remaining the same since 2025. His physician
states that they are supportive of him receiving an exemption.
Mandel Corbin
Mandel Corbin is a 56-year-old class CB CDL holder in Delaware. He
has a history of nocturnal seizure disorder and has been seizure free
since October 9, 2023. He takes an anti-seizure medication with the
dosage and frequency remaining the same since October 9, 2023. His
physician states that they are supportive of him receiving an
exemption.
Hector Corrales
Hector Corrales is a 49-year-old class C driver's license holder in
Pennsylvania. He has a history of generalized epilepsy and has been
seizure free since September 2014. He takes anti-seizure medication
with the dosage and frequency remaining the same since October 2023.
His physician states that they are supportive of him receiving an
exemption.
Mason Cross
Mason Cross is a 22-year-old class DV driver's license holder in
Alabama. He has a history of idiopathic epilepsy and has been seizure
free since May 21, 2021. He takes anti-seizure medication with the
dosage and frequency remaining the same since July 28, 2021. His
physician states that they are supportive of him receiving an
exemption.
Shantel Dalton
Shantel Dalton is a 47-year-old regular operator license holder in
Indiana. She has a history of an unprovoked seizure and has been
seizure free since August 9, 2021. She takes an anti-seizure medication
with the dosage and frequency remaining the same since 2021. Her
physician states that they are supportive of her receiving an
exemption.
Brandon Daniel
Brandon Daniel is a 51-year-old class A license holder in
Washington. He has a history of atypical meningioma and has been
seizure free since October 6, 2023. He takes anti-seizure medication
with the dosage and frequency remaining the same since 2023. His
physician states that they are supportive of him receiving an
exemption.
William Dearing
William Dearing is a 40-year-old class A CDL holder in Maryland. He
has a history of epileptic seizures and has been seizure free since
September 22, 2024. He takes an anti-seizure medication with the dosage
and frequency remaining the same since September 23, 2024. His
physician states that they are supportive of him receiving an
exemption.
Devante Dunkle
Devante Dunkle is a 28-year-old class D license holder in Alabama.
He has a history of epilepsy and has been seizure free since December
2022. He takes anti-seizure medication with the dosage and frequency
remaining the same since 2015. His physician states that they are
supportive of him receiving an exemption.
Jeffrey Eggleston
Jeffrey Eggleston is a 59-year-old class CM1 license holder in
California. He has a history of intracranial hemorrhage and has been
seizure free since December 23, 2022. He takes anti-seizure medication
with the dosage and frequency remaining the same since January 2, 2025.
His physician states that they are supportive of him receiving an
exemption.
Loren Ehrich
Loren Ehrich is an 80-year-old class A CDL holder in Iowa. He has a
history of nocturnal seizure and has been seizure free since February
5, 2024. He takes anti-seizure medication with the dosage and frequency
remaining the same since February 2024. His physician states that they
are supportive of him receiving an exemption.
Roberto Faltz
Roberto Faltz is a 55-year-old class C CDL holder in New Jersey. He
has a history of localization related seizure and has been seizure free
since February 15, 2025. He takes anti-seizure medication with the
dosage and frequency remaining the same since February 15, 2025. His
physician states
[[Page 59639]]
that they are supportive of him receiving an exemption.
John Freitag
John Freitag is a 39-year-old class F license holder in Missouri.
He has a history of seizure disorder and has been seizure free since
February 2021. He takes an anti-seizure medication with the dosage and
frequency remaining the same for over 20 years. His physician states
that they are supportive of him receiving an exemption.
Jonna Galicia
Jonna Galicia is a 22-year-old class C license holder in
California. She has a history of complex partial epilepsy and has been
seizure free since June 20, 2022. She takes an anti-seizure medication
with the dosage and frequency remaining the same since July 6, 2022.
Her physician states that they are supportive of him receiving an
exemption.
Barry Harmon
Barry Harmon is a 67-year-old class D license holder in Kentucky.
He has a history of seizures and has been seizure free since February
10, 2024. He takes an anti-seizure medication with the dosage and
frequency remaining the same since February 2024. His physician states
that they are supportive of him receiving an exemption.
Anisha Hemby
Anisha Hemby is a 46-year-old class B CDL holder in North Carolina.
She has a history of seizure disorder and has been seizure free since
October 21, 2024. She takes anti-seizure medication with the dosage and
frequency remaining the same since October 21, 2024. Her physician
states that they are supportive of her receiving an exemption.
John Kelley
John Kelley is a 45-year-old class DM regular license holder in
Wisconsin. He has a history of seizures due to an oligodendroglioma and
has been seizure free since June 15, 2019. He takes an anti-seizure
medication with the dosage and frequency remaining the same since
December 15, 2021. His physician states that they are supportive of him
receiving an exemption.
Shane Kreh
Shane Kreh is a 23-year-old class C license holder in Maryland. He
has a history of juvenile myoclonic epilepsy and has been seizure free
since 2018. He takes anti-seizure medication with the dosage and
frequency remaining the same since 2018. His physician states that they
are supportive of him receiving an exemption.
Freddy Lee
Freddy Lee is a 57-year-old class AM CDL holder in Alabama. He has
a history of epilepsy and has been seizure free since October 2021. He
takes anti-seizure medication with the dosage and frequency remaining
the same since October 2021. His physician states that they are
supportive of him receiving an exemption.
William London
William London is a 48-year-old class A CDL holder in California.
He has a history of epilepsy and has been seizure free since June 2020.
He takes an anti-seizure medication with the dosage and frequency
remaining the same since June 2020. His physician states that they are
supportive of him receiving an exemption.
Derrick Magwood
Derrick Magwood is a 40-year-old class E license holder in Florida.
He has a history of provoked seizure and has been seizure free since
2019. He takes an anti-seizure medication with the dosage and frequency
remaining the same since 2019. His physician states that they are
supportive of him receiving an exemption.
Clifton Marlow
Clifton Marlow is a 47-year-old class B CDL holder in Washington,
DC. He has a history of meningitis and has been seizure free since
October 2017. He takes anti-seizure medication with the dosage and
frequency remaining the same since August 8, 2024. His physician states
that they are supportive of him receiving an exemption.
Christian Martinez
Christian Martinez is a 47-year-old class D license holder in New
Jersey. He has a history of seizure disorder and has been seizure free
since 2022. He takes an anti-seizure medication with the dosage and
frequency remaining the same since December 3, 2022. His physician
states that they are supportive of him receiving an exemption.
Stephen Mazzali
Stephen Mazzali is a 72-year-old class A CDL holder in Idaho. He
has a history of non-intractable epilepsy and has been seizure free
since November 2020. He takes an anti-seizure medication with the
dosage and frequency remaining the same since November 2020. His
physician states that they are supportive of him receiving an
exemption.
Vincenzo Mazzella
Vincenzo Mazzella is a 31-year-old class D license holder in New
Jersey. He has a history of juvenile myoclonic seizures and has been
seizure free since April 2016. He takes an anti-seizure medication with
the dosage and frequency remaining the same since January 27, 2025. His
physician states that they are supportive of him receiving an
exemption.
Antonio Moreno
Antonio Moreno is a 48-year-old class A CDL holder in Nevada. He
has a history of complex partial epilepsy and has been seizure free
since December 8, 2022. He takes an anti-seizure medication with the
dosage and frequency remaining the same since January 25, 2024. His
physician states that they are supportive of him receiving an
exemption.
Eugene Nuss
Eugene Nuss is a 63-year-old class A CDL holder in Nebraska. He has
a history of focal seizure disorder and has been seizure free since
September 25, 2023. He takes anti-seizure medication with the dosage
and frequency remaining the same since 2023. His physician states that
they are supportive of him receiving an exemption.
Caleb Peavler
Caleb Peavler is a 28-year-old class D license holder in Kentucky.
He has a history of seizure disorder and has been seizure free since
June 2018. He takes an anti-seizure medication with the dosage and
frequency remaining the same since Spring 2023. His physician states
that they are supportive of him receiving an exemption.
Daiwik Rana
Daiwik Rana is a 24-year-old class D license holder in South
Carolina. He has a history of epilepsy and has been seizure free since
April 2022. He takes an anti-seizure medication with the dosage and
frequency remaining the same since May 2022. His physician states that
they are supportive of him receiving an exemption.
Antonio Reddick
Antonio Reddick is a 36-year-old class A CDL holder in Florida. He
has a history of a single unprovoked seizure and has been seizure free
since April 2022. He has never taken anti-seizure medication. His
physician states that they are supportive of him receiving an
exemption.
[[Page 59640]]
Preston Regier
Preston Regier is a 26-year-old regular driver's license holder in
Indiana. He has a history of complex partial seizures and has been
seizure free since May 2019. He takes anti-seizure medication with the
dosage and frequency remaining the same since February 1, 2022. His
physician states that they are supportive of him receiving an
exemption.
Tyler Revermann
Tyler Revermann is a 29-year-old class D license holder in
Minnesota. He has a history of epilepsy and has been seizure free since
July 17, 2022. He takes anti-seizure medication with the dosage and
frequency remaining the same since February 19, 2022. His physician
states that they are supportive of him receiving an exemption.
Michael Rice
Michael Rice is a 29-year-old class C license holder in Iowa. He
has a history of epilepsy and has been seizure free since July 22,
2014. He takes an anti-seizure medication with the dosage and frequency
remaining the same since September 2019. His physician states that they
are supportive of him receiving an exemption.
Stuart Richardson
Stuart Richardson is a 56-year-old class B CDL holder in New York.
He has a history of epilepsy and has been seizure free since December
2022. He takes an anti-seizure medication with the dosage and frequency
remaining the same since November 9, 2023. His physician states that
they are supportive of him receiving an exemption.
Kevin Riggenbach
Kevin Riggenbach is a 49-year-old class A license holder in Ohio.
He has a history of partial idiopathic epilepsy and has been seizure
free since October 12, 2019. He takes an anti-seizure medication with
the dosage and frequency remaining the same since October 12, 2019. His
physician states that they are supportive of him receiving an
exemption.
Christopher Robb
Christopher Robb is a 37-year-old class A license holder in Oregon.
He has a history of epilepsy and has been seizure free since 2015. He
takes an anti-seizure medication with the dosage and frequency
remaining the same since 2019. His physician states that they are
supportive of him receiving an exemption.
Michael Sheets
Michael Sheets is a 43-year-old class C license holder in North
Carolina. He has a history of epilepsy and has been seizure free since
December 2020. He takes an anti-seizure medication with the dosage and
frequency remaining the same since June 15, 2021. His physician states
that they are supportive of him receiving an exemption.
Bobby Simpson
Bobby Simpson is a 52-year-old class DA CDL holder in Kentucky. He
has a history of a glioblastoma and has been seizure free since
December 20, 2023. He takes an anti-seizure medication with the dosage
and frequency remaining the same since January 4, 2024. His physician
states that they are supportive of him receiving an exemption.
Timothy Stoddard
Timothy Stoddard is a 55-year-old class A CDL holder in Oregon. He
has a history of focal seizure disorder and has been seizure free since
February 26, 2025. He takes anti-seizure medication with the dosage and
frequency remaining the same since February 26, 2025. His physician
states that they are supportive of him receiving an exemption.
Carlos Tovar
Carlos Tovar is a 24-year-old class C license holder in Texas. He
has a history of seizure disorder and has been seizure free since
January 2, 2022. He takes an anti-seizure medication with the dosage
and frequency remaining the same since November 11, 2024. His physician
states that they are supportive of him receiving an exemption.
Joshua Trainum
Joshua Trainum is a 50-year-old class A CDL holder in Pennsylvania.
He has a history of seizure disorder and has been seizure free since
January 2018. He takes an anti-seizure medication with the dosage and
frequency remaining the same since April 4, 2018. His physician states
that they are supportive of him receiving an exemption.
Jose Luis Paz Vargas
Jose Luis Paz Vargas is a 62-year-old class A CDL holder in
Illinois. He has a history of epilepsy and has been seizure free since
November 20, 2020. He takes an anti-seizure medication with the dosage
and frequency remaining the same since 2020. His physician states that
they are supportive of him receiving an exemption.
Alexander Verduzco
Alexander Verduzco is a 33-year-old class A CDL holder in
California. He has a history of seizure disorder and has been seizure
free since December 5, 2024. He takes an anti-seizure medication with
the dosage and frequency remaining the same since February 2025. His
physician states that they are supportive of him receiving an
exemption.
David Vreeland
David Vreeland is a 51-year-old class A CDL holder in New York. He
has a history of partial epilepsy and has been seizure free since
October 17, 2023. He takes an anti-seizure medication with the dosage
and frequency remaining the same since 2023. His physician states that
they are supportive of him receiving an exemption.
Thurston Wicklund
Thurston Wicklund is a 56-year-old class B CDL holder in Minnesota.
He has a history of transient neurologic symptoms and has been seizure
free since July 5, 2023. He takes anti-seizure medication with the
dosage and frequency remaining the same since 2023. His physician
states that they are supportive of him receiving an exemption.
V. Request for Comments
In accordance with 49 U.S.C. 31136(e) and 31315(b), FMCSA requests
public comment from all interested persons on the exemption
applications described in this notice. FMCSA will consider all comments
received before the close of business on the closing date indicated
under the DATES section of the notice.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2025-23478 Filed 12-18-25; 8:45 am]
BILLING CODE 4910-EX-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 19, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.